SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (436)12/7/2003 11:51:47 PM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
NGEN Has not closed its upgap of December 3, the day it announced that it had been issued U.S. Patent "Methods for the Electronic Assembly and Fabrication of Devices", which according to the company, is the parent of a series of pending patents that significantly broaden its position in the nanotechnology area. The Company now has 56 patents in the U.S.

biz.yahoo.com

An although gaps get closed on average 90% of the time, it seems that NGEN's gap will not be closed for a while.<g>

The nearest support is at 5.28 and resistance from 6.70 to 7 <g>

Besides the good news about the patent, in NGEN favor is the fact that the revenues in the September Q were about 12% better and the loss for the Q was $0.27 vs. $0.42. For the year the company expects to have a loss of about $27 to $29M. Since there are $22.1M shares out, the loss per share is expected to be $1.22 to $1.28

The company already has a loss per share of $0.91 for the first 3 Qs and if the results come as expected, the loss for the 4thQ should be from $0.31 to $0.37/share, which should compare favorably with the $0.41 loss in the December 2002 4th Q.(That would be better earning results for 3 Qs on a roll.<g>)

The company expects revenue to improve significantly in 2004. It has around $32M in cash after it had a recent private investment of $7M which included warrants with an exercise price from $4.14 to $4.75/share.

With the caveat of the December 3rd gap, it seems worth while to keep NGEN under close watch.<g>

siliconinvestor.com

Especially since on its longer term chart, NGEN still has plenty of room to run.<g>

siliconinvestor.com

Bernard